Produkty 65700-36-9

CAS 65700-36-9 występuje w naszej ofercie pod nazwami: Bromocriptine EP Impurity C, Bromocriptine mesilate EP Impurity C, (8S)-2-Bromo-alpha-Ergocryptine, (8S)-2-Bromo-α-ergocryptine. Oferty producentów: Chemat Brand, TRC, Biosynth. Dostępne opakowania: on request, 25mg, 1mg.

Bromocriptine EP Impurity C
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Bromocriptine mesilate EP Impurity C
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
(8S)-2-Bromo-alpha-Ergocryptine
TRC
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
(8S)-2-Bromo-α-ergocryptine
Biosynth
  • opakowanie: 1mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(6aR,9S)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide (CAS 65700-36-9) to związek chemiczny o wzorze sumarycznym C32H40BrN5O5 i masie molowej 654.6 g/mol. Nazwa systematyczna IUPAC: (6aR,9S)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide. InChIKey: OZVBMTJYIDMWIL-SHUSXKRSSA-N.

Dane identyfikacyjne
Wzór sumarycznyC32H40BrN5O5
Masa molowa654.6 g/mol
Nazwa IUPAC(6aR,9S)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
InChIKeyOZVBMTJYIDMWIL-SHUSXKRSSA-N
SMILESCC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Bromocriptine Mesilate EP Impurity C, Isobromocriptine, Bromocriptine EP Impurity C, (8S)-2-Bromo alpha-ergocryptine, 8-Epibromocriptine, (8S)-2-Bromo-?-Ergocryptine, (8S)-2-Bromo-|A-Ergocryptine, 2-Bromo-alpha-ergocryptinine
Powiązane formy tego związku
(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide C32H40BrN5O5
(6aR,9R)-5-bromo-N-[(1S,2S,4S,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide C32H40BrN5O5
(6aR,9R)-5-bromo-N-[(1S,2S,4R,7R)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide C32H40BrN5O5